SUBSCRIBE
SUBSCRIBE

Immuno-oncology

Podcast
Pfizer’s $6B China Deal, Drug Pricing and FDA’s New COVID Vaccine Plan
China continues to be a source of innovation as Pfizer strikes biggest pact yet; HHS provides more info on Trump’s Most Favored Nation executive order; FDA Commissioner Marty Makary and CBER director Vinay Prasad reveal new COVID-19 vaccine strategy following Novavax approval; ODAC underway after chaotic planning; more.
May 21, 2025
 · 
2 min read
 · 
Heather McKenzie
Exploration, Currency,Hiding,Discovery,Searching, Businessman
China
Pfizer’s China Deal Worth up to $6B Eclipses Peers in a Frenzied Market
The largest Chinese licensing deal behind Pfizer’s is Novartis’ partnership with Shanghai Argo Biopharma, worth potentially more than $4 billion.
May 20, 2025
 · 
1 min read
 · 
Annalee Armstrong
Load More
PRESS RELEASES
Press Releases
Agenus to Host End-of-Year Stakeholder Webcast Featuring GI Oncology Leaders and Progress of BOT/BAL
November 20, 2025
 · 
5 min read
Press Releases
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform
November 20, 2025
 · 
6 min read
Press Releases
BioCytics Successfully Completes a Key Regulatory Milestone with Recent FDA INTERACT Meeting
November 19, 2025
 · 
2 min read
Press Releases
OSE Immunotherapeutics Announces Positive Recommendation from Independent Data Monitoring Committee (IDMC) to Continue Pivotal Phase 3 ARTEMIA Trial Evaluating Tedopi® in Non-Small Cell Lung Cancer
November 18, 2025
 · 
4 min read
Press Releases
OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology Expansion
November 17, 2025
 · 
3 min read